🟢 Amneal Pharmaceuticals is trading 4.23% up in pre-market with no clear company-specific catalyst identified

Amneal Pharmaceuticals is trading at $18.00 (+4.23%), based on the supplied pre-market quote; no clear August 14, 2026 company-specific catalyst was identified in reliable overnight coverage.

• The completed Kashiv BioSciences acquisition is among recent developments.
• Stronger second-quarter results are also recent, but neither development directly explains this morning’s move.
• Broader markets are only modestly mixed, so macro sentiment is insufficient to establish causation.